University of South Florida

Scholar Commons
Internal Medicine Faculty Publications

Internal Medicine

9-12-2014

Aging and Energetics' 'Top 40' Future Research Opportunities
2010-2013
Steven N. Austad
The University of Alabama at Birmingham

David B. Allison
The University of Alabama at Birmingham

Lisa H. Antoine
The University of Alabama at Birmingham

Scott W. Ballinger
The University of Alabama at Birmingham

Marcas M. Bamman
The University of Alabama at Birmingham

See next page for additional authors
Follow this and additional works at: https://scholarcommons.usf.edu/intmed_facpub

Scholar Commons Citation
Austad, Steven N.; Allison, David B.; Antoine, Lisa H.; Ballinger, Scott W.; Bamman, Marcas M.; Biga, Peggy;
Darley-Usmar, Victor M.; Fisher, Gordon; Gohlke, Julia M.; Halade, Ganesh V.; Hartman, John L.; Hunter,
Gary R.; Messina, Joseph L.; Nagy, Tim R.; Plaisance, Eric P.; Powell, Mickie L.; Roth, Kevin A.; Sandel,
Michael W.; Schwartz, Tonia S.; Smith, Daniel L.; Sweatt, J. David; Tollefsbol, Trygve O.; Watts, Stephen A.;
Yang, Yongbin; and Zhang, Jianhua, "Aging and Energetics' 'Top 40' Future Research Opportunities
2010-2013" (2014). Internal Medicine Faculty Publications. 49.
https://scholarcommons.usf.edu/intmed_facpub/49

This Article is brought to you for free and open access by the Internal Medicine at Scholar Commons. It has been
accepted for inclusion in Internal Medicine Faculty Publications by an authorized administrator of Scholar
Commons. For more information, please contact scholarcommons@usf.edu.

Authors
Steven N. Austad, David B. Allison, Lisa H. Antoine, Scott W. Ballinger, Marcas M. Bamman, Peggy Biga,
Victor M. Darley-Usmar, Gordon Fisher, Julia M. Gohlke, Ganesh V. Halade, John L. Hartman, Gary R.
Hunter, Joseph L. Messina, Tim R. Nagy, Eric P. Plaisance, Mickie L. Powell, Kevin A. Roth, Michael W.
Sandel, Tonia S. Schwartz, Daniel L. Smith, J. David Sweatt, Trygve O. Tollefsbol, Stephen A. Watts,
Yongbin Yang, and Jianhua Zhang

This article is available at Scholar Commons: https://scholarcommons.usf.edu/intmed_facpub/49

F1000Research 2014, 3:219 Last updated: 16 MAY 2019

REVIEW

Aging and energetics’ ‘Top 40’ future research opportunities
2010-2013 [version 1; peer review: 3 approved]
David B. Allison1-3,13,14, Lisa H. Antoine1,4,5, Scott W. Ballinger8,14,
Marcas M. Bamman3,6,14,17, Peggy Biga3,7, Victor M. Darley-Usmar3,8,16,
Gordon Fisher3,11,14, Julia M. Gohlke3,5, Ganesh V. Halade3,9, John L. Hartman3,10,
Gary R. Hunter3,11,14, Joseph L. Messina3,8,14,17, Tim R. Nagy3,12-14,
Eric P. Plaisance3,11,14, Mickie L. Powell3,7, Kevin A. Roth3,7, Michael W. Sandel3,15,
Tonia S. Schwartz2,3, Daniel L. Smith3,13, J. David Sweatt14, Trygve O. Tollefsbol3,7,
Stephen A. Watts3,7, Yongbin Yang3,12, Jianhua Zhang16, Steven N. Austad3,7,13,14
1Office of Energetics, University of Alabama at Birmingham, Birmingham, AL, USA
2School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
3Nutrition and Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA
4School of Engineering, University of Alabama at Birmingham, Birmingham, AL, USA
5Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL, USA
6Department of Cell, Developmental, & Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA
7Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA
8Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA
9Department of Medicine – Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA
10Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA
11Department of Human Studies, University of Alabama at Birmingham, Birmingham, AL, USA
12Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA
13Comprehensive Center for Healthy Aging, University of Alabama at Birmingham, Birmingham, AL, USA
14UAB Center for Exercise Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
15Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
16Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA
17Birmingham VA Medical Center, Birmingham, AL, USA

v1

First published: 12 Sep 2014, 3:219 (
https://doi.org/10.12688/f1000research.5212.1)

Open Peer Review

Latest published: 12 Sep 2014, 3:219 (
https://doi.org/10.12688/f1000research.5212.1)

Reviewer Status

Abstract
Background: As part of a coordinated effort to expand our research activity
at the interface of Aging and Energetics a team of investigators at The
University of Alabama at Birmingham systematically assayed and
catalogued the top research priorities identified in leading publications in
that domain, believing the result would be useful to the scientific community
at large.
Objective: To identify research priorities and opportunities in the domain of
aging and energetics as advocated in the 40 most cited papers related to
aging and energetics in the last 4 years.
Design: The investigators conducted a search for papers on aging and
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energetics in Scopus, ranked the resulting papers by number of times they
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Design: The investigators conducted a search for papers on aging and
energetics in Scopus, ranked the resulting papers by number of times they
were cited, and selected the ten most-cited papers in each of the four years
that include 2010 to 2013, inclusive.
Results: Ten research categories were identified from the 40 papers.
These included: (1) Calorie restriction (CR) longevity response, (2) role of
mTOR (mechanistic target of Rapamycin) and related factors in lifespan
extension, (3) nutrient effects beyond energy (especially resveratrol,
omega-3 fatty acids, and selected amino acids), 4) autophagy and
increased longevity and health, (5) aging-associated predictors of chronic
disease, (6) use and effects of mesenchymal stem cells (MSCs), (7)
telomeres relative to aging and energetics, (8) accretion and effects of body
fat, (9) the aging heart, and (10) mitochondria, reactive oxygen species,
and cellular energetics.
Conclusion: The field is rich with exciting opportunities to build upon our
existing knowledge about the relations among aspects of aging and
aspects of energetics and to better understand the mechanisms which
connect them.

2 Derek M. Huffman, Albert Einstein College of
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Introduction
Energetics can be defined as the study of the causes, mechanisms,
and consequences of the acquisition, storage, and utilization of
metabolizable energy by biological organisms. The United States –
indeed the world – is currently undergoing a crisis of excess energy
storage, sometimes called the obesity epidemic. At the same time,
the United States population is aging at an unprecedented rate with
the over 65 population expected to double by 2050, the over 85
population expected to triple, and the over 100 population expected
to more than sextuple (U.S. Administration on Aging; http://www.
aoa.gov/Aging_Statistics/future_growth/future_growth.aspx#age).
A consistent finding from ecology, basic laboratory science, and
epidemiologic research is that aspects of energetics, including the
perceived and actual availability of food, the ingestion of food, the
composition of the food consumed, the amount of body energy
accreted and expended, affect disease and disability, senescence,
mortality rate, and longevity. A team of investigators at The University of Alabama at Birmingham (UAB) is currently aiming to
advance innovative research at the interface of aging and energetics
(hereafter A&E), and in preparation took stock of what ‘the field’
was describing as the vital research needs and opportunities in this
domain. Realizing that the results of this assessment may be useful
to others working in A&E, we publish them here.

Methods/Approach
Identification of the ‘Top 40’ Articles in A&E
To identify the ‘Top 40’ Articles in A&E, we conducted the following search in Scopus: ((TITLE((aging OR ageing OR lifespan OR
longevity OR senescence)) AND PUBYEAR > 2009 AND PUBYEAR < 2014) AND (TITLE((calori* OR diet* OR energetic*
OR nutri* OR food OR fat OR adipo* OR “body composition”))
AND PUBYEAR > 2009 AND PUBYEAR < 2014)) AND (LIMITTO(LANGUAGE, “English”)).
We then ranked the papers by number of times they were cited and
selected the ten most cited papers in each of the four years that
include 2010, 2011, 2012, and 2013. This ‘normalized’ for amount
of time to be cited and resulted in a total of 40 papers (Appendix A).

Extraction of research priorities and themes
Ten of the authors then each reviewed 4 of the 40 top A&E publications and identified areas relative to A&E that were recommended by the original papers’ authors as needs for future research.
For example, we extracted statements from the publications that
included phrases like “More studies are needed on…”, “Future
work should…”, “Further studies are needed to …”, “…not yet been
established …”, and so on. Thereafter, two authors (DBA and LHA)
grouped these statements into thematic categories. This involved
some subjectivity and loss of some recommendations which did not
easily fit in any category, but seemed to capture the vast majority of
the recommendations. The ten thematic categories were labeled: 1)
CR longevity response, 2) role of mTOR and related factors in lifespan extension, 3) nutrient effects beyond energy (especially resveratrol, omega-3 fatty acids, and selected amino acids, 4) autophagy
and increased longevity and health, 5) aging-associated predictors
of chronic disease, 6) use and effects of MSCs, 7) telomeres relative to aging and energetics, 8) accretion and effects of body fat,
9) the aging heart, and 10) mitochondria, reactive oxygen species,

and cellular energetics. Specific suggestions often appeared in more
than one category.

Narrative description
We now briefly summarize the recommendations in each category.

CR longevity response
Robustness and heterogeneity of the CR longevity response
It was in rats, in 1917, that caloric restriction (CR) was first documented to extend life1. In the decades following, researchers studying model organisms as diverse as yeast, Drosophila, rodents, and
primates have accumulated experimental evidence demonstrating
that CR extends lifespan, slows the aging process, and/or improves
healthy aging biomarkers2–4. Concurrently, repeated studies within
select model species (e.g., rats) further supported the robustness
of this response4. And thus, with this mounting evidence, the antiaging response to a protocol of 20 to 40% CR was largely considered to be a robust response, evolutionarily conserved across
animals.
Intrigued by this perceived adaptive response to an obvious physiological stress, researchers began traversing the animal lineage,
beyond the traditional laboratory model organisms, to validate the
robustness of this response. Instead they found extensive heterogeneity across species in their ability to extend median or maximum
lifespan in response to CR4. Similarly, testing additional genetic
strains of lab animals uncovered extensive variation in the response
to CR within inbred, outbred, and wild-derived strains of nematodes and mice (currently over 80 strains tested)4–6. For example,
while CR has a relatively robust response in rats and C. elegans,
by causing nearly all strains tested to increase median or maximum
lifespan (~30% increase in rats); in mice this is true for only a subset of strains4. Rather, the effect of CR across mouse strains (particularly the ILSXISS) ranged from decreasing or having no effect
to increasing lifespan, with an average increase of only ~15%4.
Furthermore, this heterogeneity may be underplayed due to bias in
reporting the negative effects of CR on lifespan4. Thus, despite the
anti-aging response to CR being evolutionarily conserved, there is
now considerable evidence for heterogeneity in either the presence
or absence of the lifespan extension response, and the degree of the
effect on lifespan.
Despite this variation, researchers are actively searching for conserved molecular mechanisms underlying this response, typically
using the short-lived model organisms. Many molecular mechanisms are implicated in this response, but few have been or are
found to be consistent across species. A generalized theme is that
reprogramming of metabolism in the face of CR is key to achieving
lifespan extension2.
The current challenge is to understand the sources of this heterogeneity and to determine if the underlying molecular mechanisms
identified in the short-lived model organisms can translate to
humans2. The heterogeneity of the CR response across mice strains
depicts a role for genetic variation5. Some of the variation among
strains is linked to the ability to regulate fat metabolism, thereby
highlighting the link between body composition and aging5,7. The
genetic variation also points to the possibility for natural selection
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to act on this response, which may explain the heterogeneity across
populations and species of non-model organisms. The variable
results in repeated studies within a genetic strain points to exceptional sensitivity of the response to other environmental variables.
Indeed mammals under CR are often more susceptible to pathogens and other environmental stresses (e.g., cold stress) which may
vary among laboratories and studies4. Finally, heterogeneity among
strains likely results from differences in gene by environment interactions, such that the optimal CR protocol (e.g., level of CR, dietary
composition, developmental timing of implementation, and consistency of the regime) for producing anti-aging effects may be unique
for each genetic background or population4,7.
One important question to consider is what one might call ‘forced
inactivity’ and consequent low energy expenditure and any healthspan/lifespan consequences in caged laboratory animals. While
there is substantial heterogeneity in volume of voluntary exercise
across strains8, the main point is that lab mice will voluntarily run
some amount (and up to 11 km/day) if given a wheel, and may reap
healthspan benefits from it. The field as a whole may create animals (particularly rodents) predisposed to disease and early death
because of forced inactivity (see, e.g., 9–11).
Overall, CR is the most discussed intervention for extension of life-span. While largely, but not perfectly, evolutionarily conserved
across animals, there is extensive heterogeneity in this response
within and across species. Understanding the heterogeneity in the
response to CR at both the organismal and molecular level will be
essential for predicting the plausible effects of elements of a CR
regime or its pharmaceutical mimics to heterogeneous human
populations.

Mechanisms of the CR longevity response
Traditional thinking about CR, developed primarily with laboratory
rodents, held that a significant restriction of dietary calories relative
to ad lib feeding universally increased longevity and that energy
intake alone, rather than the amount of any particular dietary nutrient, modulated lifespan12,13. Recent research on an extended range
of model organisms makes both of those general conclusions no
longer tenable. Not only does the same CR regime that extends life
in some genotypes of mice, flies, and yeast have no effect on longevity in other genotypes14–16, it even shortens life in some genotypes
indicating less than perfect evolutionary conservation17,18. Also,
new evidence clearly indicates that restriction of some nutrients, in
particular methionine or protein generally, is sufficient for significant life extension across a range of organisms19–22. Consequently, in
some cases, the term “CR” as a descriptor of a longevity-enhancing,
reduced nutrient regime should probably be replaced with the
more generic and previously widely-used term “dietary restriction
(DR)”. The life-extending impact of nutrient reduction, where it is
observed, can be reasonably referred to as the “DR effect”.
What can these new studies, employing a broader array of species,
genotypes, and nutrient regimes than previously, suggest about
mechanisms of life extension by dietary restriction? First, the lack
of a life-extending effect, or even a life-shortening effect, of DR
in some genotypes can be informative. For instance, in a series of
recombinant inbred mouse strains, the ability of a strain to live longer

under 40% CR was significantly heritable and related to metabolic
efficiency5. Mice that lost the least weight and preserved the most
body fat under reduced calories were most likely to live longer7.
These results together suggest that allelic variation in energetic efficiency genes may underlie the DR effect. Similarly, variation in
replicative longevity in a series of 166 yeast single-gene deletion
strains implicated vacuolar pH, superoxide dismutase activity, and
mitochondrial proteome homeostasis (= proteostasis) as key determinants of the response to DR. Follow-up studies in C. elegans,
which has been evolutionarily separated from yeast for ~1 billion
years, also implicate mitochondrial proteostasis in the DR effect18.
Together these findings suggest a key role for energetic efficiency
as a central process for understanding how nutrient intake and processing affect health and longevity. Second, despite the promise of
a unified, conserved mechanism for the DR effect suggested above,
other evidence indicates more mechanistic variety. For instance, the
growth hormone (GH)/IGF-1 axis is strongly implicated in the DR
effect in mice such that: (1) reduced GH and IGF-1 signaling have
been genetically associated with longer life, (2) DR in mice reduces
signaling through these pathways, and (3) DR fails to increase longevity substantially in GH receptor knockout mice23. By contrast, in
C. elegans insulin/IGF signaling is not required for the DR effect –
at least under most DR regimes24. However, DR is implemented by
at least 12 methods in worms, differing in the culture medium, food
source, and the age at which restriction is initiated. Surprisingly, the
genetic pathways implicated in the DR effect vary depending upon
method, suggesting considerable mechanistic complexity for such
a seemingly straightforward environmental manipulation.
What does this avalanche of new information on DR across species
suggest for future research directions according to our most-cited
recent papers? First, and with most consensuses, determining the
impact on health and longevity of the relative intake of different
nutrients as well as the timing and number of calories consumed
needs refinement and re-evaluation across a range of species and
genotypes2–4,17,25–30. However true, this suggestion lacks focus and
more helpful perhaps is the linking by several papers of the DR
effect either directly or indirectly to metabolic efficiency5,18,26 and
the maintenance of proteostasis20,25,31,32. With respect to this latter
process, the most commonly adduced mediator of proteostasis was
modulation of mTOR activity2,25,26,32,33. Herein lies the most focused
suggestion for future research to arise from our most-cited papers.

Role of mTOR and related factors in lifespan extension
The mTOR kinase integrates signals from nutrients, energy status,
growth factors, and a variety of stressors and affects, among other
things, the rate of protein synthesis and degradation via autophagy
by a host of downstream effectors34. Thus TOR inhibition is a major
player in the management of cellular energy and the maintenance of
the proteome with aging. A number of our top-cited papers emphasize that the link between health, aging, nutrition, and energetics
would be dramatically advanced by increased knowledge of how
various nutrient and caloric manipulations affect and integrate both
upstream mediators and downstream effectors of TOR activity, particularly on a tissue-specific basis.
Rapamycin, a macrolide with immunomodulatory properties, and
the product of the bacterium Streptomyces hygroscopius, was found
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to inhibit an evolutionarily conserved protein belonging to the
phosphatidyl inositol kinase-related serine/threonine kinase family,
referred to as mTOR, the mechanistic target of rapamycin2,25,26,35.
Modulating the mTOR signaling network affects mRNA translation,
transcription, autophagy, ribosomal biogenesis, metabolism and cell
survival, proliferation, cell size and growth, endoplasmic reticulum
stress signaling, and other stress responses26. In mammals, CR, or
reduced dietary protein or essential amino acid intake, can extend
longevity, improve metabolic fitness, and increase stress resistance, at least in part via inhibition of mTOR activity25. Nutrients
(glucose, amino acids, especially leucine, and fatty acids) directly
activate the mTOR pathway and also increase insulin levels, which
can additionally activate mTOR35. mTOR acts as a major signaling
hub, integrating multiple inputs and mediating the switch between
growth and somatic maintenance to extend lifespan26. Mammalian
cells have a single mTOR kinase which exists in two structurally
and functionally distinct multiprotein complexes: mTORC1 and
mTORC2. mTORC1 is acutely inhibited by rapamycin, although
chronic rapamycin administration inhibits mTORC2 as well36.
Amino acid deprivation is also a powerful inhibitor of mTORC1
activity even the presence of acute growth factor stimulation25,26.
Strong inhibition of mTORC1 early in life drastically slows or
even stops development, but administration of rapamycin or other
inhibitors of mTORC1 late in life causes lifespan extension, boosts
immune function and rejuvenates hematopoietic stem cells25,26.
The specific upstream mechanisms directly responsible for amino
acid sensing which are permissive of mTOR activation remains
unresolved, but localization of the mTORC1 complex has emerged
as an important aspect of amino acid mediated control25 (see Figure 1
and Figure 2). The mTORC1 pathway controls protein synthesis
most directly by phosphorylating and inhibiting a repressor of capdependent mRNA translation, 4E-BP1. mTORC1 also regulates
translation indirectly through activation of S6 kinase (S6K) whose
substrate is the ribosomal protein S6, a component of the 40S ribosome important for translation26.
A drop in the cell’s energy content is reflected in the rise of the
AMP/ATP ratio activating AMPK, which reduces the activity of
mTORC1 by direct phosphorylation of TSC2 (Tuberous Sclerosis Complex 2), a negative regulator of mTORC1, and Raptor,
an essential binding partner for the induction of translation by
mTORC12,26. Biochemical evidence places AMPK upstream of
mTORC1, but AMPK has also been shown to be downstream of
S6K and can mediate S6K dependent effects on lifespan. Similarly,
S6K is directly downstream of mTORC1, but via its inhibitory
effect on IRS1 and 2, it is also upstream of mTORC1 via an insulinsignaling route34. The complex biochemical interactions among the
various players in the mTOR network clearly require more refined
mechanistic investigation26. Thus, mTORC1, S6K and AMPK may
constitute a complex feedback loop sensitive to dietary restriction
which can redirect growth, metabolism and lifespan. In addition
to nutrients and growth factors, appropriate control of growth also
requires integration of information on environmental stresses.
Osmotic stress, hypoxia, ER stress, genotoxic stress, mechanical
forces, and contraction (e.g., muscle movement) may all regulate
mTORC1 activity26.

Key questions that still need to be delineated are how multiple
nutrients, growth factors and stress inputs are integrated into a
single mTORC1 activity level; how the physiological responses
downstream of mTORC1 are differentially regulated; how mTOR
mediates changes in survival and lifespan in response to various
environmental manipulations, especially nutrients; how the sexdependent effects of mTORC1 signaling on longevity are regulated; with multiple mechanisms proposed; how mTORC1 activity
couples nutrient availability to ribosome biogenesis; and which
transcription factors involved in mediating stress responses are regulated by mTORC1 signaling to affect lifespan extension? Furthermore, the downstream effectors of mTORC1 are not sufficiently
determined to understand which pathways are absolutely necessary
for mTORC1’s role in lifespan extension. The role of mTORC1 is
likely to be highly tissue specific, and the communication between
cells, tissues, and organs to determine lifespan is a major knowledge gap. Lastly, little is known about the role of mTORC1 in primate aging and life extension by CR in those primate populations
in which such extension is seen2,25,26,28,35.

Nutrient effects beyond energy (especially resveratrol,
omega-3 fatty acids, and selected amino acids)
In addition to the well-recognized effect of CR on longevity and
disease, there is growing evidence that the abundance of individual
nutrients, macronutrient types, and nutritional supplements (i.e.,
non-caloric dietary compounds) specifically influence health and
longevity. For example, restriction of the essential amino acid,
methionine, can improve health and increase longevity in mice
and rats, although importantly too much restriction can compromise health as well21,37,38. Methionine restriction provides benefits
independent of caloric intake (i.e., with ad lib feeding). Although
mechanistic differences are not fully understood, one possibility
is that specific pathways sensitive to dietary nutrients can be targeted to alter lifespan. Examples include amino acid signaling with
the mTOR pathway, energy status sensing through the adenosine
monophosphate kinase (AMPK) pathway, oxidative stress through
SKN1/Nrf2, protein quality control though enhanced autophagy
and the general stress response. A variety of perturbations may activate ‘longevity’ pathways such as these to promote better health.
There is also evidence accumulating that plant-based, bioactive
compounds (phytochemicals) have a variety of cellular effects and
also work through multiple pathways. While a focused approach is
helpful for establishing cause-effect for individual compounds, it is
becoming clear that we must understand combinations of dietary
effects and their interactions to fully describe the biological complexity underlying their contributions to homeostatic control and
cellular regulation. For instance, one of the most well-known, and
highly-researched CR mimetics (compounds which are proposed
to mimic the benefits of CR without the necessity of energy intake
reduction) is resveratrol, a polyphenol found in the skins of red
grapes, muscadines, etc. Resveratrol is proposed to possess multiple
agonist (sirtuins, AMPK) and antagonist (TOR/S6K, heat shock
response) activities to pathways which have been genetically demonstrated to mediate longevity and health outcomes. Yet, the effects
of resveratrol remain open to question. Resveratrol has not yielded
consistent results on longevity outcomes, but it remains a highly
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Figure 1. Upstream of mTOR: classical and non-classical inputs. a | Growth factors such as insulin stimulate PI3K to generate
phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3), which promotes the phosphorylation (P) of AKT at Thr308 by phosphoinositidedependent kinase 1 (PDK1). AKT phosphorylates tuberous sclerosis complex 2 (TSC2) on multiple sites to inhibit its GTPase-activating protein
(GAP) activity for the small GTPase RAS homologue enriched in brain (RHEB). GTP-loaded RHEB then activates mammalian TOR complex
1 (mTORC1). Growth factors also stimulate mTORC2 by promoting its association with ribosomes in a PI3K-dependent manner. b | Amino
acids stimulate mTORC1 by promoting the conversion of RAS-related GTP-binding protein (RAG) heterodimers to the active conformation, in
which RAGA or RAGB is loaded with GTP and RAGC or RAGD is loaded with GDP. c | In response to low energy (high AMP/ATP ratio), AMPactivated protein kinase (AMPK) phosphorylates regulatory-associated protein of mTOR (RAPTOR) at Ser792 and TSC2 at Ser1387, leading
to the inhibition of mTORC1. d | During the inhibition of the Hippo pathway component large tumour suppressor homologue (LATS) kinase,
hypophosphorylated Yes-associated protein (YAP) translocates to the nucleus and promotes the expression of the microRNA miR-29. miR-29
targets PTEN mRNA and inhibits PTEN translation, which leads to increased levels of PtdIns(3,4,5)P3 and the activation of both mTORC1 and
mTORC2. Dashed arrows represent translocation of the molecule. e | Glycogen synthase kinase 3β (GSK3β) activates the TSC complex by
phosphorylating TSC2 at Ser1379 and Ser1383. Phosphorylation of these two residues requires priming by AMPK-dependent phosphorylation
of Ser1387. WNT signalling inhibits GSK3β and the TSC complex, and thus activates mTORC1. mTORC2 is activated by WNT in a manner
dependent on the small GTPase RAC1. Proteins shown in green promote mTOR activity or their activity is promoted by mTOR. Proteins shown
in red inhibit mTOR activity or their activity is inhibited by mTOR. Phosphorylation depicted in yellow is an activation signal and phosphorylation
depicted in orange is an inhibitory signal. 4E-BP, eIF4E-binding protein; APC, adenomatous polyposis coli; GPCR, G protein-coupled receptor;
GRB10, growth factor receptor-bound protein 10; IGF, insulin-like growth factor 1;IRS1, insulin receptor substrate 1; LRP, low-density lipoprotein
receptor-related protein; mLST8, mammalian lethal with SEC thirteen 8; RICTOR, rapamycin-insensitive companion of mTOR; S6K, ribosomal
S6 kinase; SIN1, SAPK-interacting 1; TBC1D7, TBC1 (TRE2–BUB2–CDC16) domain family member 7; ULK1, UNC-51-like kinase 1.
This figure has been reproduced with kind permission from Shimobayashi M, Hall M. Making new contacts: the mTOR network in metabolism
and signalling crosstalk. Nature Reviews Molecular Cell Biology 2014;15:155–162.
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Figure 2. mTOR controls metabolism. Mammalian TOR complex 1 (mTORC1) promotes anabolic processes, such as the biosynthesis of
proteins, nucleotides and lipids, and inhibits catabolic processes such as autophagy. Aa | mTORC1 phosphorylates (P) the hydrophobic motif
(Thr389) in ribosomal S6 kinase (S6K), thereby activating it to subsequently phosphorylate ribosomal protein S6 at the sites indicated to promote
ribosome biogenesis. mTORC1 also phosphorylates eIF4E-binding protein (4E-BP) at multiple sites to inhibit it. Inhibition of 4E-BP stimulates
translation initiation, especially of 5′ oligopyrimidine tract (termed a 5′ TOP) and pyrimidine-rich translational element (PRTE) containing
mRNAs. Ab | mTORC1 stimulates nucleotide and lipid synthesis. mTORC1 promotes the gene expression of key enzymes in the pentose
phosphate pathway (PPP), at least in part by activating sterol regulatory element-binding proteins (SREBPs). mTORC1 also stimulates CAD
(Gln-dependent carbamoyl-phosphate synthase, Asp carbamoyltransferase, dihydroorotase) by S6K-mediated phosphorylation at Ser1859,
which leads to CAD activation and the stimulation of de novo pyrimidine synthesis. Furthermore, mTORC1 promotes lipogenic gene expression
by activating S6K or by inhibiting the nuclear translocation of LIPIN1, both of which activate the transcription factor SREBP. Ac | mTORC1
inhibits autophagy by phosphorylating UNC-51-like kinase 1 (ULK1) at Ser758 and ATG14 at multiple sites. During mTORC1 inhibition, AMPK
phosphorylates ULK1 at Ser317, and thereby activates ULK1, which phosphorylates Beclin 1 in the vacuolar protein sorting 34 (VPS34)–Beclin
1–ATG14 complex to initiate autophagy. mTORC1 also inhibits autophagy indirectly by blocking lysosome biogenesis, by phosphorylating and
inhibiting the nuclear translocation of transcription factor EB (TFEB). B | mTORC2 co-translationally phosphorylates AKT at Thr450 to prevent
its ubiquitylation and degradation. mTORC2 also post-translationally phosphorylates ATK at Ser473 to promote lipogenic gene expression by
activation of SREBP1c. Moreover, mTORC2 co-translationally phosphorylates IGF2 mRNA-binding protein 1 (IMP1) at Ser181, which stimulates
insulin-like growth factor 2 (IGF2) production. The activity of proteins shown in green is promoted by mTOR. The activity of proteins shown in
red is inhibited by mTOR. Phosphorylation depicted in yellow is an activation signal and phosphorylation depicted in red is an inhibitory signal.
Dashed arrows represent translocation of the protein. mLST8, mammalian lethal with SEC thirteen 8; PDK, phosphoinositide-dependent kinase
1; RAPTOR, regulatory-associated protein of mTOR; RICTOR, rapamycin-insensitive companion of mTOR; SIN1, SAPK-interacting 1.
This figure has been reproduced with kind permission from Shimobayashi M, Hall M. Making new contacts: the mTOR network in metabolism
and signalling crosstalk. Nature Reviews Molecular Cell Biology 2014;15:155–162.
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researched phytochemical that may mediate disease risk or cellular/
tissue health through other of these multiple interactions. Mice
appear “largely unaffected by resveratrol”40.
An alternative approach to pathway specific targeting is exemplified in omega-3 fatty acid research. Polyunsaturated fatty acids
(PUFAs), which contain double bonds in their carbon backbone, can
be subdivided in various families, with the ‘omega-3’ (double bond
at the n-3 position) type PUFA garnering the most health claims.
This may be related to the change in the structure and biochemical
properties of the lipid that provides important components of cellular membranes and protection from oxidative stress, particularly
in the central nervous system where omega-3s are concentrated in
nervous tissues. Although dietary deficiency has been associated
with neurodegenerative disease risk and accelerated aging, supplementation with omega-3s (above the accepted minimum requirement) to slow aging and reduce disease requires further testing. In
fact it is a common conundrum in the nutrition/metabolism research
field as to what constitutes nutritional deficiency or excess, and
whether compensatory nutritional alterations (supplementation or
restriction of the ‘required’ amount, or simply removing an ‘excess’
or ‘deficiency’) affect healthspan or lifespan. Thus, by definition,
causes and mediators of aging require not just the alleviation of a
disease inducing state, but promotion of a health maintaining state
that reduces disease risk, while increasing health span and longevity.
To help address this question, a recent study investigated the effect
of macronutrient balance on longevity in mice by testing 10 diet
compositions at 3 energy densities, and found that mTOR signaling
responded to the dietary protein content (increased mTOR signaling with more protein), raising the possibility that compounds like
rapamycin which have significant longevity effects and alter amino
acid signaling, may be modified by the background dietary protein
and/or amino acid content. Alternatively, varied dietary compositions having different macronutrient proportions, individual nutrient
restrictions, impaired nutrient metabolism, etc. could be modified
to reduce signaling through pro-aging pathways, thereby increasing
health and longevity. Whether this is the underlying mechanism(s)
by which CR exerts its varied health benefits requires future study.
However, manipulations of the diet by compound inclusion or individual nutrient restrictions, because they permit unrestricted intake,
remains a type of intervention that more people will likely accept
than CR as a change in their lifestyle.

Autophagy and increased longevity and health
Aging and senescence are associated with accumulation of damaged
proteins and organelles, mitochondrial dysfunction, and metabolic
imbalance, especially in post-mitotic cells41–48. These pathologies
further exacerbate cell injury, resulting in organ failure and decreased
lifespan. While the oxidative stress theory of aging has been
explored, except in limited examples using gene knockout or overexpression of antioxidant enzymes, there is a general lack of correlation between the levels of antioxidants and lifespan49–55. Since
proteins and organelles are normally cleared by the autophagylysosomal activity, an emerging concept for regulation of aging and
lifespan is that autophagy-lysosomal activity becomes deficient in
aging32,56–67.
In general, it has been shown that autophagy is regulated at many
levels, by nutrient availability, oxidative and reductive stress,

hypoxia and pathogenic molecules68,69. When this activity is unable
to meet the demand for clearance of damaged intracellular macromolecules and organelles, pathologies emerge and progress. For
example, perturbation of autophagy is evident in neurodegenerative diseases including Alzheimer’s and Parkinson’s diseases70,71.
In yeast, worms, flies, and mammals, insufficient autophagy contributes to accumulation of protein aggregates and dysfunctional
mitochondria, thereby leading to a decrease in lifespan and the
pathogenesis and progression of various age-dependent chronic
diseases56,57,59. In addition, inhibition of autophagy leads to deterioration in mitochondrial function72,73; for example, ATG7-deficient
skeletal muscles and pancreatic β cells accumulate dysmorphic
mitochondria and exhibit defective oxidative phosphorylation73. In
addition PINK1 knockout mice exhibit mitochondrial dysfunction
in striatum, liver, brain tissue, and primary cortical neurons74,75.
In a complementary series of studies, a role for the beneficial effects
of stimulating autophagy in healthy aging has emerged based on
data from longevity studies in various models31,60–62,64,65,76,77. Rapamycin, which inhibits mTORC1 activity and activates autophagy,
has been shown to extend lifespan in several model organisms76–78.
CR and resveratrol have also been shown to extend lifespan
through SIRT1-mediated activation of autophagy in worms31, and
genetic manipulations of autophagy also extend lifespan in animal
models57,60,62,64,65.
While autophagy is an attractive therapeutic target for increasing
life and health span, key questions remain regarding our understanding of the fundamental mechanisms of autophagic regulation,
as well as the impact of autophagy activation on lifespan and health
span. Investigations of these key questions are essential to our ability to fully exploit this pathway for improving healthy aging, longevity, and associated drug development.
One critical aspect is already clear – that the fundamental mechanisms of autophagy regulation are context-dependent. For example,
autophagic activation in response to oxidative stress is differentially
regulated from autophagy activated by starvation. Determining the
relevant common and specific autophagy mechanisms, and identifying the signaling pathways that modulate the level, location and
selectivity of autophagy, are crucial for a better understanding of
autophagy in aging. Regarding our understanding of the impact of
autophagy on aging, age-related disease and longevity, we must take
into account that current animal studies are predominantly undertaken using relatively pathogen- and nemesis-free environments.
How we translate these studies to humans is still an unanswered
question. Epidemiologic studies can give important clues in this
regard, although pinpointing a specific contribution of autophagy
on life and health span in human longevity studies remains a technical challenge.
An interesting and topical aspect is the extent to which individual
variation in the autophagy pathway impacts healthy aging. Understanding the genetic variants in the human population which modulate autophagy is a largely unexplored aspect of genomic studies,
yet will be essential as we enter the era of personalized health care.
Perhaps metabolomics, proteomics, or bioenergetics health indices
need to be developed using imaging, accessible biopsies or body
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fluid to provide the much-needed paradigm shifts in our understanding of, and capacity for, monitoring human health conditions80–82.
Additionally, autophagy activation may have differential impact on
different organs in terms of their function and longevity. If improving health span is what we desire, then how to define health is not as
simple as it appears. What one person defines as a healthy circumstance, another person may find unacceptable. Thus, we may have
to be able to distinguish health and illnesses of different organs in
any given person.
The emerging autophagy theory of aging holds tremendous promise, but is clearly a part of a bigger story, and integration into the
existing paradigms should be considered at the outset. For example, autophagy can be included into the metabolism theory of
aging, which includes metabolism of metabolites, reactive species, proteins, and organelles. Another example is the hormesis
theory, which suggests that weak stress induces adaptive changes
in the organism and may correlate with longevity30,48,55,82,83, thus, as
Nietzsche opined, what does not kill you may make you stronger.

Aging-associated predictors of chronic disease
Expansion of adipose tissue during positive energy balance is a
primary determinant of obesity and related pathophysiological
sequalae84,85. In contrast to the long-held belief that pro-inflammatory
signals exert a negative impact on metabolism, emerging studies
suggest that proinflammatory signaling is required for adipose tissue
remodeling and expansion85. In fact, impairments in the pro-inflammatory response of adipose tissue were shown to increase ectopic
lipid accumulation, glucose intolerance and systemic inflammation.
In a related fashion, adipose tissue acquires a pro-inflammatory and
senescent-like state with aging independent of adiposity86. Although
macrophage infiltration is thought to be responsible for much of
the increase in inflammation with obesity, infiltration is lower with
aging in the absence of obesity suggesting that pro-inflammatory
responses to aging may be mediated to reduce ectopic lipid storage.
Possible evidence for this, described in a recent review86, indicates
that the pro-inflammatory cascade with aging in adipose tissue is
mediated through preadipocytes. It is possible that progenitor turnover, higher fatty acid levels, and toxic metabolites may contribute
to fat cell senescence which then increases release of pro-inflammatory cytokines, increasing the potential for senescence to spread
locally from cell to cell. It is important to determine whether the
pro-inflammatory cascade that occurs with aging is derived from an
aging-induced attempt to sequester lipids in relevant adipose storage sites as opposed to deleterious storage in ectopic sites such as
skeletal muscle and liver.
As described in previous sections, CR extends lifespan in rodents
and controversially in non-human primates as well29,87. At least part
of the mechanism by which CR extends lifespan is through reductions in all-cause mortality. In fact, prolonged CR lowers body fat,
slows rate of muscle loss, and lowers the incidence of neoplasia, diabetes, and cardiovascular disease in rhesus monkeys29. In addition,
reproductive endpoints and brain morphology are preserved with
CR. Since CR has been initiated at an early age in most studies,
future studies are warranted to understand the effects of CR when
initiated in adulthood. It is particularly important to understand
the effects of CR following prolonged positive energy balance in

adult rodents and non-human primates. Since recent human studies
have suggested that exercise training can ameliorate the negative
consequences of weight gain, it would be particularly beneficial to
observe the effects of exercise training (forced or voluntary) during
periods of CR and weight gain. Observation of mitochondrial function during these periods of CR and caloric surplus combined with
either exercise training or no training would also be of great value.
Dietary restriction of the essential amino acid methionine has been
shown to increase lifespan in rodents38 suggesting that restriction of
total calories is not an absolute requirement for extending lifespan.
While restricting fat and carbohydrate intake produces no extension of lifespan or improvements in markers of aging, improvements in the quality of carbohydrate consumption may be involved.
Along these lines, a lower glycemic index (GI) diet can attenuate
blood glucose excursions, lower postprandial lipemia, and decrease
inflammatory markers. This is critical as many of these processes
have been linked to age-related macular degeneration (AMD) and
other aging associated diseases. Recent work by Uchiki et al.88,
using mouse and cell models, revealed that consumption of higher
GI diets may increase risk for AMD and other aging diseases by
increasing glycative stress-associated lesions in several different
tissue compartments. The increase in advanced glycation end products (AGE) were due to a decrease in both the ubiquitin-proteasome
system and lysosome/autophagy pathway, which are critical for
degrading AGEs. Thus, it appears that one potential mechanism
by which a higher GI diet can increase risk for AMD and other
diseases is by altering cellular proteolytic activity. Future studies
should be conducted to elucidate additional biological mechanisms
by which consumption of a lower GI diet can promote health.

Use and effects of mesenchymal stem cells (MSCs)
Significant changes in fat mass and distribution occur during aging
and the redistribution of adipocytes in the elderly has been linked
with a number of age-related disorders. Notably, about 15–50% of
the cells in adipocyte tissue comprise preadipocytes that give rise to
fat cells89 and that play major roles in the mass and distribution of
adipocyte cells during aging. Preadipocytes arise from adult stem
cells in mammalian organs and one of the most important types of
adult stem cell is the MSC. These are multipotent stromal cells that
can differentiate into not only adipocytes, but also osteoblasts and
chondrocytes as well as other cell types. Although MSCs have a
high capacity for self-renewal, their ability to proliferate and differentiate decrease during aging, and with increasing passage number
in vitro90,91. Considerable interest has focused on the mechanisms
of MSC proliferation and differentiation that may provide novel
approaches for tissue regeneration, a cornerstone of advances in
interventional aging research.
Recent work by Vidal et al.91 provides important insights into the
senescence of MSCs that are central to organismal aging. To determine the potential use of MSCs in regenerative medicine, three
different types of equine MSCs, bone marrow (BMSC), adipose
tissue (ASC) and umbilical cord tissue (UCMSC), were evaluated
for onset of cellular senescence in culture which has direct implications in their use for regenerative measures during aging, especially
of fat and bone. It was discovered that BMSCs senesce after fewer
population doublings than ASCs and UCMSCs demonstrating the
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more limited use of these types of MSCs for tissue regeneration.
This also suggests that adipose and umbilical cord tissue may be
preferable for tissue banking purposes although further studies on
MSCs from different tissue sources are sorely needed in order to
fully elucidate the potential for future therapeutic strategies in tissue repair during aging92. Potential differences in methodology,
however, could account for some of the reported results of limited
capacity of BMSCs for tissue regeneration and additional studies
will be required for optimization and standardization of cell culture
conditions for the different types of MSCs. Also, yet unsolved is the
differentiation potential of the various MSCs (BMSCs, ASCs and
UCMSCs) at higher passage, since loss of differentiation potential
could severely limit their ability to create new tissue for regenerative medicine and their application in the elderly.
A number of intriguing questions have arisen with respect to the
mechanisms responsible for the attenuation of MSC proliferation
and differentiation potential during aging. Among these remaining enigmas is whether senescence can occur at any stage of life86,
which is clearly important with respect to the role of MSCs during aging. It is also not yet clear if senescence can spread from
cell to cell in fat tissue in vivo or whether cellular senescence is a
key cause for metabolic dysfunction secondary to age- and obesityrelated changes in adipose tissue86. Future studies will also need
to be directed toward determining if a senescence-like state can
develop in terminally differentiated cells. Although there are suggestions that all of these venues are important with respect to
MSCs, considerable additional research will be required before the
role of MSCs in aging and their potential in tissue regeneration can
be fully appreciated.
As aforementioned, MSCs are preadipocyte cells that give rise to
new fat cells. The MSC progenitor cells can produce osteoblasts
as well as macrophages that produce mesenchymal adipocyte-like
default (MAD) cells important in age-related fat tissue redistribution and metabolic dysfunction. However, the variation in macrophage content during aging in subcutaneous fat tissue has shown
little change while changes were noted between age and percent
of macrophages in human omental adipose tissue92. This suggests
that additional studies are required and that MSCs and subsequent
macrophage distributions and abundance during aging among fat
deposits will require considerable future investigation.
Lastly, MSCs are also central to bone marrow fat during aging and
in age-related diseases such as diabetes. It is noteworthy that fat
occupies a significant proportion of bone marrow; although its role
in aging and age-associated disease is not well understood. A recent
investigation by Krings et al.93 suggests that important changes
occur in bone marrow fat not only during aging, but also in diabetes.
MSCs give rise to different types of fat such as brown and white
adipose tissue (BAT and WAT, respectively) and the metabolic phenotypes of bone marrow fat have characteristics of both types of adipose tissue. It was found that a decrease in BAT-like characteristics
with aging and diabetes may contribute to age-related loss of bone
remodeling and hematopoiesis that could have important implications in a number of changes that occur with aging secondary to
the dynamics of MSCs in bone marrow93. This may create avenues
for therapeutic interventions for bone integrity during aging and in

age-associated diseases in addition to regenerative medicine possibilities for skeletal tissue. However, future studies will be required
to determine the role of MSCs in bone marrow during aging and
metabolic diseases especially with respect to their lineage identity
and differential adipose content in bone marrow.
Taken together, although a number of studies have eloquently
revealed many of the roles of MSCs with respect to aging and agerelated diseases, there are many avenues for additional studies to
further reveal (1) the dynamics of cellular senescence in vivo and
how this may limit potential for regenerative medicine approaches,
(2) the behavior of MSCs from different tissue sources during
aging, (3) the mechanisms for senescence of MSCs and how this
impacts not only the aging process itself, but advances in intervention of aging and age-associated diseases, (4) the distribution
and abundance of MSCs and macrophages during aging among fat
depots, and (5) the role of MSCs in bone marrow and the importance of MSCs in contributing to maintenance of skeletal integrity
in the elderly. Clearly many important advances have contributed
significantly to our understanding of MSCs and their roles in aging;
although many key questions remain that will provide fertile ground
for future investigations.

Telomeres relative to aging and energetics
Telomeres, the repetitive sequences at the end of chromosomes that
buffer the genetic coding regions, suffer from attrition during successive cycles of DNA replication and cellular division. The telomerase enzyme, responsible for the maintenance of telomere length,
is thought to be active in germ-line cells, but relatively inactive in
differentiated tissues in humans. Thus, the gradual erosion of the
chromosome ends is proposed to contribute to genetic instability
and loss under conditions of replicative stress and over the course
of life94. When a critically short telomere length is reached, the cell
enters replicative senescence and can no longer contribute to regenerative needs of the particular tissue95.
Telomere length is variable between individuals at birth and with
the proliferative demands of different body tissues, telomere length
can vary between tissues within an individual94. Previous research
has shown that shortened telomeres are associated with a number of
metabolic- and age-related pathologies (e.g. oxidative stress, inflammation) and diseases (cardiovascular, diabetes, cancer, obesity)96–99.
Controlling for individual variations in telomere length by using
intra-individual telomere length, estimated attrition is further associated with potential contributors insulin resistance, a proposed
mediator of metabolic-related disease and aging100.
From a broader comparative perspective, humans have relatively
short telomeres yet age more slowly and live significantly longer
than other mammals. Despite these interspecies differences, the
observed associations between telomere length and attrition suggest
there may be additional information to be learned by understanding
the physiologic contributors to telomere attrition that overlap with
aging modulation. In this regard, a recent review discussing the
obesity-mortality association has highlighted a number of gaps in
the current knowledge99. For instance, there is a known association
between excess body weight as measured by body mass index (BMI)
and morbidity/mortality, yet there are exceptions where individuals
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with high-BMIs can have better than average health outcomes.
Whether this BMI-mortality association is due to inter-individual
differences in cellular aging rates, which may be captured through
monitoring telomere change with body mass change, remains to
be seen. Similarly, within individuals, whether telomere attrition
is a composite outcome of age-sensitive biological mediators (oxidative stress, inflammation) that would reliably predict morbidity
and mortality remains to be demonstrated. Along this same line,
longitudinal studies of telomere dynamics within specific interventions to accelerate or retard aging (e.g., high fat diet feeding vs.
dietary restriction), and including early life exposures and late-life
health outcomes to better understand the “early life programming”
effect in disease risk, could be informative. Such studies should
include measures of caloric intake, energy balance, body composition, non-caloric nutritional factors associated with telomere length
maintenance, stress exposure/protection, and co-morbidities in the
outcomes. For the present, there is strong consensus that telomere
shortening can contribute to cellular health and replicative capacity, and telomere length is correlated with a number of energeticand age-associated negative health outcomes. Although it is not yet
clear that telomere length or attrition is causative in these cases,
particularly for mortality in humans, future research will require
identifying the most relevant metric of telomere length (shortest
single chromosome telomere length vs. population mean or overall distribution, etc.) and using such information to assess whether
telomere attrition is more of a biomarker or causative factor in agerelated phenotypes.

Accretion and effects of body fat
Aging is generally associated with increases in total adiposity as well
as waist circumference despite a lack of change or even a reduction
in body weight (or concomitant decreases in lean mass)37,101. Positive energy balance, as resulted from subtle decreases in physical
activity and basal metabolic rate that are not matched by decreases
in energy intake, is suggested to be the cause for this increased
adiposity101. During advanced old age, while total amount of fat
mass tends to decline or remains stable, fat is redistributed from
subcutaneous to intra-abdominal visceral depots and to ectopic
sites, including muscle (cardiac and skeletal), liver and bone marrow86,89. Fat redistribution and fat tissue dysregulaton with aging
occurs across species and is associated with age-related diseases,
lipotoxicity, changed metabolic variables and reduced longevity,
with some of these changes more closely related to regional adipose
tissue distribution than total fat mass89,93. These changes might be
explained by the increased systemic free fatty acid exposure caused
by impaired capacity of fat tissue to store lipid89. Total or regional
fat distribution with aging could have influence on morbidity and
mortality risk, for example the removal of visceral fat significantly
prolonged lifespan in rats101,102. In humans, weight gain and visceral
adiposity is strongly associated with diabetes, atherosclerosis,
thrombiosis, hypertension and other age-related diseases103. It is
also notable that there appears to be protective effects of aerobic
fitness on all-cause mortality, even at high levels of adiposity. Poor
aerobic fitness is a powerful predictor of all-cause mortality across
a wide BMI range104,105.
Brown adipose tissue (BAT), which is related to thermal dysregulation and energy imbalance, decreases with aging in both animals

and humans89. However, it is unclear whether the decline in BAT is
related to the white adipose tissue changes with aging. With aging,
midfacial fat compartments have an inferior migration and volume
shift106.
Preadipocytes, comprising a significant proportion of cells in adipose tissue, are constantly giving rise to new fat cells throughout
life, but with aging they are less capable of accumulating lipid than
are cells from younger individuals, which may contribute to the
increased abundance of small, insulin-resistant, dysfunctional fat
cells89. Preadipocytes also have decreased replication and adipogenesis, and increased proinflammatory cytokines and susceptibility to lipotoxicity with age86.
Fat, which was once thought of as a largely biologically inert lipid
storage depot, also plays an important role in the regulation of
energy metabolism, thermoregulation, inflammation, and immune
responses that is implemented through a number of adipokines
derived from adipose tissue2,93. Adiponectin, a cytokine primarily
originating from adipose tissue, has been shown to negatively correlate with many age- and obesity-related diseases and positively
correlate with longevity in mice107,108. Similarly, leptin, which has
been shown to modulate total body fat and visceral fat distribution,
might play a causative role in the metabolic decline in aging independent of fat mass109,110. As in obesity, aging is frequently associated with increased fat tissue and circulating pro-inflammatory
cytokines secreted by dysfunctional fat cells, including tumor
necrosis factors-α (TNF-α) and interleukin (IL-6)86, which in turn
alter T lymphocyte subsets and attract mast cells and cause monocyte recruitment and macrophage activation89. Macrophages infiltrate adipose tissue of obese animals and humans more extensively
in visceral fat than subcutaneous fat. Animal studies show macrophages and pro-inflammatory factors increase with aging mainly
in subcutaneous fat but remain constantly high in visceral fat
throughout life, which implicates that subcutaneous fat gets dysfunctional with aging, potentially contributing to fat redistribution86,89.
Under CR, proportionally more body fat is lost than other tissue,
which may contribute to alterations in systemic metabolic homeostasis, influencing factors at the interface of metabolism and inflammation37. In aging studies utilizing non-human primates, CR lowers
body weight, decreases fat mass and improves insulin sensitivity29,37.
One of the most striking effects of CR in non-human primates is the
impact on body composition, especially fat mass in the abdominal
region29. A study on rats has shown that CR improves carbohydrate
metabolism in aging by decreasing visceral fat111. Thus it is suggested that interventions that stimulate metabolism and/or activate
WAT signaling hold great promise as mimics of CR37. However,
it is not clear yet whether CR is as effective in non-overweight
individuals or certain stages of lifespan. Furthermore, it is advisable to titrate allocations in already fat-depleted animals in order to
guard against drawing on lean tissue for energy since food intake
steadily declines after middle age29.

The aging heart
Although other organs were discussed in the top 40 papers that we
reviewed, the heart received particular emphasis. Congestive heart
failure is an age-associated disease and is the direct result of defective
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cardiac aging112. The results from these studies suggest that fibrosis
is a common consequence of myocardial infarction (MI) in older
adults, but less common in younger adults113. The heart is a complex
organ beating non-stop and is composed of 2 main cell types, cardiomyocytes and fibroblasts, along with pacemaker cells, Purkinje
fibers, smooth muscle cells, resident macrophages, endothelial and
epicardial cells, and a pool of resident stem cells. With aging, cardiomyocytes tend to either develop hypertrophy or wear and tear leading to necrosis. Fibroblast dysfunction with age leading to fibrosis,
primarily contributes to diastolic heart failure in elderly individuals. Following a heart attack aging fibroblasts fail to develop stable
scars and there is extensive left ventricle dilation and reduced survival in aging rodents and elderly individuals113,114. Novel strategies
are required to reduce wear and tear in cardiomyocytes and preserve fibroblast function in order to form mature matrix in left ventricle remodeling in aging. Therapies are under investigation that
stimulate cardiomyocyte regenerative capacity and limit fibrotic
progress, but in the majority of cases, aging, the main confounding
factor, is ignored.
Hypertension is highly associated with aging and congestive heart
failure. Congestive heart failure significantly reduces cardiac output and limits functional capacity and quality of life. Age-related
increases in the PR (PQ) interval (> 200 ms; distance on an ECG
from the start of electrical conduction in the atria (beginning of p
wave) to the start of electrical conduction in the ventricles (beginning of q wave) are positively associated with increased incidence
of heart failure115. The relationship between ECG Pwave to Rwave
interval (PRI) and heart failure has important clinical implications
suggesting that monitoring of PRI may be a cost-effective strategy to identify individuals at increased risk for adverse outcomes
associated with aging. Additional large-scale studies are needed to
more precisely identify the magnitude of PRI prolongation over the
lifespan. Future human studies should incorporate younger participants to elucidate the relationship between PRI and heart failure.
In addition, an important area of investigation will be to determine
if lifestyle interventions such as exercise and/or energy restriction
(in the presence or absence of weight loss) reduces age-associated
prolongation of PRI and subsequent incidence of heart failure and
atrial fibrillation. Further validation with echocardiographic data
such as chamber size and left ventricular mass are also crucial for
clinical utility of the PRI in predicting adverse outcomes in multiple
race/ethnicities.
Control of inflammation is a widely studied approach for the treatment of MI, based on evidence from population-based studies.
These studies suggest a direct role of inflammatory cytokines such
as IL-6 and TNF-α on heart failure development116. Over the last
thirty years, use of anti-inflammatory treatments has been discouraged
for the treatment of post-MI inflammation in heart failure pathology. The reason for this is that studies with older animals indicate
that aberrant inflammatory responses – either defective or overactive –are associated with worse outcomes, in particular reduced
collagen deposition in response to injury. Interestingly, the reverse
of what is observed in young animals. Therefore, an anti-fibrotic
or anti-inflammatory strategy needs to be used with caution in
older individuals. For example, methyl prednisolone treatment has
been reported to cause ventricular rupture in humans and specific

cyclooxygenase 2 inhibitors in fact induce more MI events. TNF-α
trials too have so far failed to meet the expectation of cardiologist for heart failure treatment117–119. Thus, in the last three decades
anti-inflammatory approaches have not been shown to be effective.
Therefore, novel targets with a major focus on the resolution of
inflammation are necessary.
Lindsey et al.120 showed that aging alters extracellular matrix remodeling and observed that middle aged (15 month-old) and older (23
month-old) CB6F1 mice had increased soluble protein fraction and
decreased insoluble collagen compared to young mice. These structural changes are accompanied by increased end-diastolic dimension and ventricular wall thickness in aging mice with increased
metalloproteinases (MMPs-3,8,9,12) and decreased inhibitory factors (TIMPs-3 and 4) expression. Thus, functional and proliferative
capacites of fibroblasts are essential to maintain degraded matrix
and to ensure that the structural integrity of the left ventricle is
maintained in aging120.
Age-related increases in fibrosis are also observed in C57Bl/6J
sarcopenic and aging mice. Senescent (~32 month-old) C57BL/6J
mice developed left ventricle structural changes characterized as
interstitial fibrosis leading to increased left ventricular end diastolic
dimension, decreased wall thickness, and decreased ejection fraction, indicating reduced contractile performance due to fibrosis.
Thus, collectively preventative strategies are required to prevent
ventricular fibrosis in aging121. While developing prevention strategies, the post-MI therapeutic treatments are needed to maintain
survival of cardiomyocte and preserve fibroblast function mainly
focusing on resolution of inflammation rather than inhibition in the
reparative phase of remodeling of the aging heart.

Mitochondria, reactive oxygen species, and cellular
energetics
Denham Harman originally proposed the “free radical theory of
aging” in 1956, which was later refined to the “mitochondrial theory
of aging” in 1970’s. The common theme in both was that oxidative damage accumulates with age; inclusion of the latter implicated
reactive oxygen species generated by mitochondria as the primary
source of this stress. This theory has been intensively explored
– some studies have provided results consistent with this theory,
whereas the majority has not. For example, in some cases oxidative stress increased lifespan, and other reports have shown that
increased mitochondrial DNA (mtDNA) mutation associated with
decreased function, without a concomitant increase in oxidative
stress, is sufficient for generating a premature aging phenotype. At
the inception of both these ideas the central paradigm for the free
radical field was “oxidative stress” in which the simple concept was
that the aging was accelerated by an imbalance between oxidants
and antioxidants. The hypothesis was later refined to encompass data
that suggested that mitochondrial superoxide and hydrogen peroxide were uncontrolled “leaks” from electron transfer and mitochondria were the major source of reactive species in the cell. Since the
1970’s it is clear that both concepts are not supported by experimental evidence and cannot encompass the role of reactive species such
as hydrogen peroxide, nitric oxide and electrophilic lipids as cell
signaling molecules71,122,123. Mitochondria are clearly not the major
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source of reactive species in the cell and whole families of proteins
have now been discovered which show the controlled production
of superoxide, nitric oxide, hydrogen peroxide and other reactive
species with which the mitochondria interact in cell signaling cascades122,124–126. Consequently, mitochondrial function may prove to
have a more critical role in aging, not because of its generation of
damaging ROS, but because of its role in cell signaling.

to include immune response. The focus in the redox biology field
has now shifted to understand why and how the “quality” of the
mitochondrial population in cells declines with age and integrates
concepts from autophagy, cell signaling and bioenergetics71,130,131.
Of particular interest is autophagy and mitochondrial biogenesis
since they are both biological pathways that can link CR with
healthy aging and bioenergetics37,132.

It is instructive to consider the evolution of mitochondria, which are
ancient bacterial symbionts with their own genetic and protein synthesis systems, to understand the fundamental nature of mitochondrial signaling to the cell, sometimes called retrograde signaling127.
Each cell can contain hundreds to thousands of mitochondria each
of which contains multiple copies of mtDNA. The mtDNA encodes
genes essential for electron transport and oxidative phosphorylation. A unique aspect of mitochondria is that the proteins required
for its multiple functions are encoded by both nuclear and mitochondrial genomes, requiring coordination and communication
between the two cellular compartments. While reminiscent of its
endosymbiotic origins, the mitochondrion retained many of the
catalytic subunits required for electron transport and ATP synthase
in its mtDNA. Hence, any mutation within the mtDNA has the
potential to modify mitochondrial bioenergetics. In this respect, it
has been proposed that prehistoric mutations in the mtDNA modulated the economics of mitochondrial production in the interrelated
functions of ATP (energy), heat (thermoregulation), and superoxide
(which can be converted to H2O2 and act as a signaling molecule)
production, enabling our ancestors to successfully establish populations northward as they migrated from Africa. MtDNA mutations in
northern migrants decreased caloric utilization for ATP generation
while increasing that used for generating heat, creating a metabolic
advantage for survival in colder climates. Although decreasing
mitochondrial economy (in terms of ATP generation per calorie
consumed), these changes were accommodated by changes in diet
(increased caloric intake associated with animal fats). By comparison, mtDNA mutation that increased caloric utilization for ATP
(thus decreasing energy lost to heat production) would be better
adapted to low calorie diets and warmer climates (e.g., sub-Saharan
Africa). In contemporary society, these prehistoric adaptations of
mitochondrial economy can affect mitochondrial health and influence susceptibility to age-related disease in a setting of chronic
positive energy balance72,128. In support of these concepts are molecular epidemiologic studies that correlate both human longevity and
disease risk with certain mtDNA polymorphisms. More recently, it
has been shown that mtDNA can directly influence susceptibility to
heart failure and hepatic steatosis in mice, consistent with concepts
of mitochondrial – nuclear genetic interactions129. Hence, the role
of the mitochondrion in aging is most likely multi-faceted due to its
multiple cellular functions that include bioenergetics and signaling.
More recently, studies have implicated mtDNA as a DAMP (damage associated molecular pattern) broadening its cellular functions

Hence, assessment of mitochondrial health in a dynamic fashion
in our aging populations may provide a means for understanding
the basis and progression of many forms of age-related diseases,
including neurodegenerative diseases, diabetes, cardiovascular disease, liver disease, and cancer. This has now become possible with
the development of measures of bioenergetic health from the leukocytes and platelets isolated from human subjects133,134.

Conclusion
In conclusion, across forty of the most cited papers at the interface
of aging and energetics published in the last four years, we were
able to identify ten major themes of research suggestions. We have
summarized them here for the interested investigator.
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In order to make conclusions about the current consensus on mechanisms involved in the very broad field
of aging and energetics (broadly defined as the acquisition, storage and utilization of metabolizable
energy by biological organisms), the authors have utilized a novel methodology for determining what
researchers regard as the top 40 relevant publications over the period of 2011 through 2013, as
ascertained via a broad search algorithm and ranked by the number of citations over that time period.
Their analysis of these selected papers provide an interesting selection of some ten overlapping domains,
including such ”old timers” as caloric restriction (now more accurately referred to as dietary restriction)
and the new star of the field, mTOR signaling.
While this approach is an important guidepost to what has been discovered and, more importantly, as
revealed by their analysis, what more needs to be done, the authors are encouraged to add an interesting
and potentially informative control consisting of the lower 40 most cited papers revealed by their search
algorithm. Such an exercise has the potential to reveal highly novel ideas that, perhaps 10 or so years
from now, could result in a new flowering of publications that might transform some segments of this
exceedingly complicated family of nature-nature interactions.
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Here, the authors summarize 40 of the most widely-cited papers on energetics and aging over the last 4
years by themes, including suggested priorities from those publications for future work. Overall, I think this
article does a good job of highlighting and summarizing state-of-the-art aspects of several broad and
complex topics. Discussion of the heterogeneity of the caloric restriction (CR) response was particularly
warranted. The implementation and interpretation of CR studies requires careful consideration of among
things, the intervention timing (early or later in life), diet quality, the control group ( ad libitum or mildly
restricted) as well as the dose. Indeed, some strains that respond negatively to 40% CR, may respond
differently at lower levels of restriction, in part due to reasons alluded to by the authors when discussing
the potential risk of further fat depletion in already lean animals or humans. The authors also highlight
some important recent observations regarding the role of specific nutrients (methionine) and botanical
compounds (resveratrol) on aging, that do not involve calories per se. Of note, this has been further
supported by a recent study that did not make the list (Levine et al., 2014), linking protein intake with
IGF-1 levels, cancer and mortality risk in younger, but not older humans.
Specific cellular mechanisms of interest are also discussed, with a particular emphasis on mTOR
signaling in modulating organismal aging, and its interplay with nutrients and hormones. Rapamycin
studies have driven much of the interest in this area, but metformin, which is not discussed here, is
frequently and safely used clinically to treat diabetes, and may act in part via similar pathways, and has
been linked to less cardiovascular disease, cognitive decline, cancers and improved survival in humans
(see Bannister et al., 2014). Overall, this is a well conceived and timely review of recent highly-cited
papers linking aging and energetics that deserves revisiting in another 4 years.
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This is an interesting manuscript describing top research priorities in the aging and energetics field based
on ideas extracted from recent papers. The title and abstract are appropriate and represent the
information presented in the body of the manuscript. The basis of the paper is atypical in that the data
generated are not assay-based but literature-based. The design is again, different but reasonable based
on the outcomes to be generated. The data generated are ranked to identify the most highly cited papers
in the past 4 years (2009<2014) and then further narrowed to 40 highly cited papers. The authors
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in the past 4 years (2009<2014) and then further narrowed to 40 highly cited papers. The authors
identified the top ten areas related to aging and energetics focusing on recommendations within these
papers as to where further work should be focused. These areas included the CR longevity response,
nutrient effects beyond energy, autophagy, mitochondria, ROS and cellular energetics and
age-associated predictors of chronic disease among others. The recommendations for continued work in
the areas covered were directed, insightful, and addressed strengths and weaknesses of the published
studies and the area in general. Overall, the manuscript was well-written and provided important direction
to those in the field in a relatively unbiased manner.
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